Y-Biologics

BiotechnologySeries DDaejeon, South Koreaybiologics.com/kr

Latest round

Series D

Last raised

Sep 2020

Total raised

$26M

Investors

11

About Y-Biologics

Based in Daejeon, South Korea, and founded in 2007, Y-Biologics Inc. operates as a biotechnology company involved in the research and development of antibody drugs and provides its clients with new drugs that reduce the propagation of cancerous cells.5 million shares at KRW 9,000 per share, within the expected price range of KRW 9,000 and KRW 11,000 on the KOSDAQ. The firm is working on exploring antibodies to create new therapeutics. The antibiotic research and development company has developed YBL-006 which is an antibody immuno-anticancer drug, Alice is a technology that activates T-immune cells, and the activated T-immune cells immediately kill cancer cells. As of 2021, the firm has generated a total comprehensive income of KRW 17,070,885,026.

Who invested in Y-Biologics

11 investors across 3 rounds

See all investors in Y-Biologics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Sep 21, 2020

    Amount

    $17M

    Investors

    Locked

  2. Series B

    Apr 8, 2016

    Amount

    $8.7M

    Investors

    Locked

  3. Seed

    Oct 1, 2015

    Amount

    $0.1M

    Investors

    Locked

Questions about Y-Biologics

Who invested in Y-Biologics?

Y-Biologics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Y-Biologics raised?

Y-Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Y-Biologics last raise money?

Y-Biologics's most recent round on record is a Series D, in Sep 2020.

What does Y-Biologics do?

Based in Daejeon, South Korea, and founded in 2007, Y-Biologics Inc.

Where is Y-Biologics headquartered?

Y-Biologics is headquartered in Daejeon, South Korea.

Which VCs invest in companies like Y-Biologics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Y-Biologics's stage. Their profiles are linked below.

Raising like Y-Biologics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.